Safety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437c
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: FCN-437c|DRUG: Letrozole 2.5mg
Sponsor: Ahon Pharmaceutical Co., Ltd.
Collaborators: Fudan University|Zhejiang Cancer Hospital|Sir Run Run Shaw Hospital